HCM
GILD icon

Horrell Capital Management’s Gilead Sciences GILD Stock Holding History

Horrell Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-600
Closed -$59K – 248
2015
Q1 		$59K Hold
600
– – 0.03% 171
2014
Q4 		$57K Hold
600
– – 0.03% 174
2014
Q3 		$64K Hold
600
– – 0.03% 166
2014
Q2 		$50K Hold
600
– – 0.02% 183
2014
Q1 		$43K Hold
600
– – 0.02% 180
2013
Q4 		$45K Hold
600
– – 0.02% 175
2013
Q3 		$38K Hold
600
– – 0.02% 177
2013
Q2 		$31K Buy
+600
New +$31.3K 0.02% 191

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Horrell Capital Management's GILD Position: Q2 2015 in Review

Horrell Capital Management sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 600 shares — an estimated $59K sold.

Horrell Capital Management first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $64K in Q3 2014. 1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Horrell Capital Management reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Horrell Capital Management sold 600 Gilead Sciences shares in Q2 2015, an estimated $59K.
  • Horrell Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
  • Horrell Capital Management's Gilead Sciences position peaked at $64K in Q3 2014.
  • 1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Horrell Capital Management's 13F filing for Q2 2015, filed 21 Jul 2015.